PTPN6 and hepatocellular carcinoma: The small molecule SC43, a derivative of the kinase inhibitor sorafenib, has been described to activate Shp1 in hepatocellular carcinoma cells, leading to dephosphorylation of downstream signaling proteins, including STAT3 (41, 42).